One drug used to prevent HIV transmission during pregnancy shows evidence of developmental effects

[From Medicalxpress, Feb 22, 2016] The antiretroviral (ARV) drug atazanavir—sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy—may have small but significant effects on infant development, reports a study in the journal AIDS.

For more, click here.